HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,067,511 | -9.1% | 43,803 | -19.2% | 0.00% | -50.0% |
Q2 2023 | $5,573,237 | -82.0% | 54,188 | -80.8% | 0.00% | -77.8% |
Q1 2023 | $30,882,964 | +59.2% | 282,966 | +66.0% | 0.01% | +50.0% |
Q4 2022 | $19,393,910 | +50.2% | 170,421 | -18.3% | 0.01% | +50.0% |
Q3 2022 | $12,910,000 | -42.5% | 208,598 | -25.9% | 0.00% | -42.9% |
Q2 2022 | $22,459,000 | -43.2% | 281,588 | -25.1% | 0.01% | -30.0% |
Q1 2022 | $39,537,000 | -3.6% | 375,795 | -1.3% | 0.01% | 0.0% |
Q4 2021 | $41,012,000 | -80.1% | 380,592 | -79.8% | 0.01% | -77.8% |
Q3 2021 | $205,981,000 | +47.4% | 1,880,413 | +26.0% | 0.04% | +45.2% |
Q2 2021 | $139,750,000 | +12.6% | 1,492,418 | +10.7% | 0.03% | +10.7% |
Q1 2021 | $124,082,000 | +20.2% | 1,348,129 | -4.5% | 0.03% | +12.0% |
Q4 2020 | $103,223,000 | +40.5% | 1,411,116 | +49.2% | 0.02% | +25.0% |
Q3 2020 | $73,477,000 | +138.2% | 945,887 | +70.5% | 0.02% | +122.2% |
Q2 2020 | $30,842,000 | +222.3% | 554,922 | +71.8% | 0.01% | +200.0% |
Q1 2020 | $9,569,000 | -20.4% | 323,076 | -2.8% | 0.00% | 0.0% |
Q4 2019 | $12,028,000 | +19.2% | 332,227 | -10.3% | 0.00% | 0.0% |
Q3 2019 | $10,090,000 | +59.1% | 370,516 | +40.6% | 0.00% | +50.0% |
Q2 2019 | $6,341,000 | – | 263,563 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |